← Back to Search

Probiotic

Kefir for Critically Ill Patients

Phase < 1
Waitlist Available
Led By Lioudmila Karnatovskaia, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if giving kefir, a drink with good bacteria, is safe and helpful for very sick adults. Kefir is a fermented milk drink with probiotic properties, historically used for its health benefits in various conditions.

Eligible Conditions
  • Critically Ill Patients

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adverse Events
Feasibility of Kefir administration

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Kefir administration in critically ill adultsExperimental Treatment1 Intervention
Critically ill subjects will receive Kefir throughout the length of their ICU course in an ascending dosing regimen
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Kefir
2020
Completed Early Phase 1
~380

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,339 Previous Clinical Trials
3,062,091 Total Patients Enrolled
Lioudmila Karnatovskaia, MDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
340 Total Patients Enrolled

Media Library

Kefir (Probiotic) Clinical Trial Eligibility Overview. Trial Name: NCT05416814 — Phase < 1
Critically Ill Patients Research Study Groups: Kefir administration in critically ill adults
Critically Ill Patients Clinical Trial 2023: Kefir Highlights & Side Effects. Trial Name: NCT05416814 — Phase < 1
Kefir (Probiotic) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05416814 — Phase < 1
~16 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top